Brief: Altamira Therapeutics Ltd Files For Offering 3.2 Mln Of Common Shares - SEC Filing
March 7 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS LTD FILES FOR OFFERING 3.2 MILLION
OF
COMMON SHARES ON A FIRM COMMITMENT BASIS - SEC FILING
* ALTAMIRA THERAPEUTICS LTD - FINAL PUBLIC OFFERING PRICE
WILL BE
DETERMINED THROUGH NEGOTIATION BETWEEN CO AND REPRESENTATIVE OF
UNDERWRITERS
Source text for Eikon: ID:
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering